GW PHARMACEUTICALS PLC - FORM 10-K - EX-23.1 - February 26, 2021

Attached files

file filename
10-K - 10-K - GW PHARMACEUTICALS PLCgwph-10k_20201231.htm
EX-32.1 - EX-32.1 - GW PHARMACEUTICALS PLCgwph-ex321_10.htm
EX-31.2 - EX-31.2 - GW PHARMACEUTICALS PLCgwph-ex312_12.htm
EX-31.1 - EX-31.1 - GW PHARMACEUTICALS PLCgwph-ex311_11.htm
EX-21.1 - EX-21.1 - GW PHARMACEUTICALS PLCgwph-ex211_8.htm
EX-10.55 - EX-10.55 - GW PHARMACEUTICALS PLCgwph-ex1055_134.htm
EX-10.54 - EX-10.54 - GW PHARMACEUTICALS PLCgwph-ex1054_135.htm
EX-10.53 - EX-10.53 - GW PHARMACEUTICALS PLCgwph-ex1053_126.htm
EX-10.52 - EX-10.52 - GW PHARMACEUTICALS PLCgwph-ex1052_130.htm
EX-10.51 - EX-10.51 - GW PHARMACEUTICALS PLCgwph-ex1051_128.htm
EX-10.50 - EX-10.50 - GW PHARMACEUTICALS PLCgwph-ex1050_131.htm
EX-10.49 - EX-10.49 - GW PHARMACEUTICALS PLCgwph-ex1049_132.htm
EX-10.48 - EX-10.48 - GW PHARMACEUTICALS PLCgwph-ex1048_129.htm
EX-10.47 - EX-10.47 - GW PHARMACEUTICALS PLCgwph-ex1047_127.htm
EX-10.46 - EX-10.46 - GW PHARMACEUTICALS PLCgwph-ex1046_133.htm
EX-10.45 - EX-10.45 - GW PHARMACEUTICALS PLCgwph-ex1045_125.htm
EX-4.4 - EX-4.4 - GW PHARMACEUTICALS PLCgwph-ex44_40.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statement Nos. 333-238737, 333-217328 and 333-204389 on Form S-8 and Registration Statement No. 333-229308 on Form S-3 of our report dated February 26, 2021, relating to the financial statements of GW Pharmaceuticals plc and its subsidiaries (the “Company”) and the effectiveness of the Company’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.

 

/s/ DELOITTE & TOUCHE LLP

 

San Diego, California

February 26, 2021

 

 

 

 

GW PHARMACEUTICALS PLC Reports